Page last updated: 2024-12-07
diethylphosphorocyanidate
Description
Research Excerpts
Clinical Trials
Roles
Classes
Pathways
Study Profile
Bioassays
Related Drugs
Related Conditions
Protein Interactions
Research Growth
Market Indicators
Description
diethylphosphorocyanidate: reagent for solid phase peptide synthesis; structure [Medical Subject Headings (MeSH), National Library of Medicine, extracted Dec-2023]
Cross-References
ID Source | ID |
---|---|
PubMed CID | 76257 |
SCHEMBL ID | 6486 |
MeSH ID | M0057358 |
Synonyms (49)
Synonym |
---|
4-03-00-00265 (beilstein handbook reference) |
pad4wpz7t0 , |
unii-pad4wpz7t0 |
phosphorocyanidic acid, diethyl ester |
diethyl cyanophosphonate |
diethoxy-phosphoryl cyanide |
diethyl cyanidophosphate |
diethylphosphorocyanidate |
phosphorocyanidic acid, o,o-diethyl ester |
diethyl cyanophosphosphonate |
diethylcyanophosphate |
einecs 220-936-5 |
diethyl phosphorocyanidate |
brn 1768938 |
diethyl cyanophosphonate, 90% |
C1242 |
cyanophosphonic acid diethyl ester |
2942-58-7 |
diethoxyphosphorylformonitrile |
diethyl cyanophosphate |
diethoxyphosphorylmethanenitrile |
A819915 |
diethyl phosphoryl cyanide |
BP-11721 |
FT-0624833 |
STL373439 |
AKOS015909598 |
BBL027776 |
SCHEMBL6486 |
diethyl-cyanophosphonate |
diethylcyano-phosphonate |
diethylcyanophosphoric acid |
diethoxy-phosphorylformonitrile |
diethylphosphoro cyanidate |
diethyl cyano-phosphate |
diethoxyphosphoryl-formonitrile |
diethylcyanophosphonate |
diethyl phosphoro-cyanidate |
(eto)2p(o)cn |
diethyl cyanoposphonate |
diethyl-cyanphosphonate |
STR04861 |
DTXSID90183639 |
mfcd00010256 |
F16281 |
J-017510 |
Q3008049 |
diethoxyphosphoryl cyanide |
EN300-105912 |
[information is derived through text-mining from research data collected from National Library of Medicine (NLM), extracted Dec-2023]
Research
Studies (9)
Timeframe | Studies, This Drug (%) | All Drugs % |
---|---|---|
pre-1990 | 2 (22.22) | 18.7374 |
1990's | 1 (11.11) | 18.2507 |
2000's | 0 (0.00) | 29.6817 |
2010's | 5 (55.56) | 24.3611 |
2020's | 1 (11.11) | 2.80 |
[information is prepared from research data collected from National Library of Medicine (NLM), extracted Dec-2023] |
Market Indicators
Research Demand Index: 12.00
According to the monthly volume, diversity, and competition of internet searches for this compound, as well the volume and growth of publications, there is estimated to be weak demand-to-supply ratio for research on this compound.
| This Compound (12.00) All Compounds (24.57) |
Study Types
Publication Type | This drug (%) | All Drugs (%) |
---|---|---|
Trials | 0 (0.00%) | 5.53% |
Reviews | 1 (11.11%) | 6.00% |
Case Studies | 0 (0.00%) | 4.05% |
Observational | 0 (0.00%) | 0.25% |
Other | 8 (88.89%) | 84.16% |
[information is prepared from research data collected from National Library of Medicine (NLM), extracted Dec-2023] |